Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses.

Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Saccá L, Bellastella A.

J Clin Endocrinol Metab. 1993 Dec;77(6):1671-6.

PMID:
8263158
3.

Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.

Amato G, Mazziotti G, Di Somma C, Lalli E, De Felice G, Conte M, Rotondi M, Pietrosante M, Lombardi G, Bellastella A, Carella C, Colao A.

J Clin Endocrinol Metab. 2000 Oct;85(10):3720-5.

PMID:
11061530
4.

Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.

Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M.

J Clin Endocrinol Metab. 2000 Nov;85(11):4104-12.

PMID:
11095440
5.

Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.

Biller BM, Sesmilo G, Baum HB, Hayden D, Schoenfeld D, Klibanski A.

J Clin Endocrinol Metab. 2000 Mar;85(3):970-6.

PMID:
10720025
6.

Body composition and quality of life in adults with growth hormone deficiency; effects of low-dose growth hormone replacement.

Ahmad AM, Hopkins MT, Thomas J, Ibrahim H, Fraser WD, Vora JP.

Clin Endocrinol (Oxf). 2001 Jun;54(6):709-17.

PMID:
11422104
7.

Effect of long-term growth-hormone substitution therapy on bone mineral density and parameters of bone metabolism in adult patients with growth hormone deficiency.

Kotzmann H, Riedl M, Bernecker P, Clodi M, Kainberger F, Kaider A, Woloszczuk W, Luger A.

Calcif Tissue Int. 1998 Jan;62(1):40-6.

PMID:
9405732
8.

Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.

Sartorio A, Ortolani S, Galbiati E, Conte G, Vangeli V, Arosio M, Porretti S, Faglia G.

J Endocrinol Invest. 2001 Apr;24(4):224-30.

PMID:
11383908
9.

A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices.

Götherström G, Svensson J, Koranyi J, Alpsten M, Bosaeus I, Bengtsson B, Johannsson G.

J Clin Endocrinol Metab. 2001 Oct;86(10):4657-65.

PMID:
11600522
10.

Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adults.

Ezzat S, Fear S, Gaillard RC, Gayle C, Landy H, Marcovitz S, Mattioni T, Nussey S, Rees A, Svanberg E.

J Clin Endocrinol Metab. 2002 Jun;87(6):2725-33. Erratum in: J Clin Endocrinol Metab 2002 Oct;87(10):4461.

PMID:
12050241
11.

Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.

Franco C, Johannsson G, Bengtsson BA, Svensson J.

J Clin Endocrinol Metab. 2006 Nov;91(11):4408-14.

PMID:
16940452
12.

Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.

Bengtsson BA, Edén S, Lönn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tölli J, Sjöström L, Isaksson OG.

J Clin Endocrinol Metab. 1993 Feb;76(2):309-17.

PMID:
8432773
13.

Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults.

Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J.

Clin Endocrinol (Oxf). 1998 May;48(5):561-8.

PMID:
9666867
14.

Long-term growth hormone replacement therapy in hypopituitary adults.

Verhelst J, Abs R.

Drugs. 2002;62(16):2399-412. Review.

PMID:
12396230
16.

Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency.

Saggese G, Baroncelli GI, Bertelloni S, Cinquanta L, Di Nero G.

J Pediatr. 1993 Jan;122(1):37-45.

PMID:
8419613
17.

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA.

Clin Endocrinol (Oxf). 1997 Oct;47(4):439-46.

PMID:
9404442
18.

Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.

Jørgensen JO, Vahl N, Hansen TB, Skjaerbaek C, Fisker S, Orskov H, Hagen C, Christiansen JS.

Clin Endocrinol (Oxf). 1998 Apr;48(4):479-86.

PMID:
9640415
19.

Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.

Chrisoulidou A, Beshyah SA, Rutherford O, Spinks TJ, Mayet J, Kyd P, Anyaoku V, Haida A, Ariff B, Murphy M, Thomas E, Robinson S, Foale R, Johnston DG.

J Clin Endocrinol Metab. 2000 Oct;85(10):3762-9.

PMID:
11061536
20.

The effects of GH replacement therapy on cardiac morphology and function, exercise capacity and serum lipids in elderly patients with GH deficiency.

Elgzyri T, Castenfors J, Hägg E, Backman C, Thorén M, Bramnert M.

Clin Endocrinol (Oxf). 2004 Jul;61(1):113-22.

PMID:
15212653
Items per page

Supplemental Content

Support Center